Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Oberg
L Vrang

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
AIDS (London, England)|February 1, 1997
Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005D Böttiger, N G Johansson, B Samuelsson, et al.
Virology|October 1, 1993
Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activityL Goobar-Larsson, K Bäckbro, T Unge, et al.
Pharmacology & Therapeutics|January 1, 1989
Antiviral effects of phosphonoformate (PFA, foscarnet sodium)B Oberg
Clinical Biomechanics (Bristol, Avon)|August 7, 2013
Lower extremity muscle strength in soccer playersB Oberg
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitorsJ Balzarini, A Karlsson, A M Vandamme, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1986
Antiviral chemotherapy against HTLV-III/LAV infectionsB Oberg
European Journal of Biochemistry|April 30, 1971
Carbethoxylation of polynucleotidesB Oberg
Biochimica Et Biophysica Acta|April 15, 1970
Biochemical and biological characteristics of carbethoxylated poliovirus and viral RNAB Oberg
Lakartidningen|November 27, 1991
[More drugs against HIV/AIDS will soon be available as a review over the drug development shows]B Oberg
Pharmacology & Therapeutics|January 1, 1982
Antiviral effects of phosphonoformate (PFA, foscarnet sodium)B Oberg
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
AIDS (London, England)|February 1, 1997
Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005D Böttiger, N G Johansson, B Samuelsson, et al.
Virology|October 1, 1993
Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activityL Goobar-Larsson, K Bäckbro, T Unge, et al.
Pharmacology & Therapeutics|January 1, 1989
Antiviral effects of phosphonoformate (PFA, foscarnet sodium)B Oberg
Clinical Biomechanics (Bristol, Avon)|August 7, 2013
Lower extremity muscle strength in soccer playersB Oberg
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitorsJ Balzarini, A Karlsson, A M Vandamme, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1986
Antiviral chemotherapy against HTLV-III/LAV infectionsB Oberg
European Journal of Biochemistry|April 30, 1971
Carbethoxylation of polynucleotidesB Oberg
Biochimica Et Biophysica Acta|April 15, 1970
Biochemical and biological characteristics of carbethoxylated poliovirus and viral RNAB Oberg
Lakartidningen|November 27, 1991
[More drugs against HIV/AIDS will soon be available as a review over the drug development shows]B Oberg
Pharmacology & Therapeutics|January 1, 1982
Antiviral effects of phosphonoformate (PFA, foscarnet sodium)B Oberg
Pageof 22